Cardiac Emergency References

Feb. 6, 2006 - Natural Products Industry INSIDER
"Cardiac Emergency" References

1. Trichopoulou A et al. “Mediterranean diet and survival among patients with coronary heart disease in Greece.” Arch Intern Med. 165, 8:929-35, 2005. http://archinte.ama-assn.org

2. Bazzano LA et al. "Dietary fiber intake and reduced risk of coronary heart disease in U.S. men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study." Arch Intern Med. 163, 16:1897-904, 2003. http://archinte.ama-assn.org

3. Mozaffarian D et al. "Cereal, fruit and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals." JAMA. 289, 13:1659-66, 2003. www.jama.com

4. Pereira MA et al. "Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies." Arch Intern Med. 164, 4:370-6, 2004. http://archinte.ama-assn.org

5. Hu FB et al. “Dietary protein and risk of ischemic heart disease in women.” AJCN. 70, 2:221-7, 1999. www.ajcn.org

6. Willmot M et al. “A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.” Nitric Oxide. 12, 3:141-9, 2005. http://www.sciencedirect.com/science/journal/10898603

7. Noguchi T et al. "Nutritional prevention on hypertension, cerebral hemodynamics and thrombosis in stroke-prone spontaneously hypertensive rats." Cell Mol Neurobiol. 24, 5:599-638, 2004.

8. Regensteiner JG et al. "Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes." Vasc Med. 8, 3:169-75, 2003.

9. Sakai K et al. “Overexpression of eNOS in brain stem reduces enhanced sympathetic drive in mice with myocardial infarction.’ Am J Physiol Heart Circ Physiol. 289, 5:H2159-66, 2005. http://ajpheart.physiology.org

10. Rakhmatullina FF et al. “The course of experimental myocardial infarction under conditions of Suppressed and enhanced NO synthesis.” Bull Exp Biol Med. 139, 4:384-7, 2005.

11. Bednarz B et al. “Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial.” Kardiol Pol. 62, 5:421-7, 2005.

12. Schulman SP et al. “L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.” JAMA. 295, 1:58-64, 2006. www.jama.com

13. Herrera MD et al. "Endothelium-dependent vasorelaxation induced by L-carnitine in isolated aorta from normotensive and hypertensive rats." J Pharm Pharmacol. 54, 10:1423-7, 2002. http://jpp.pharmpress.com/content/html/index.htm

14. Sethi R et al. “Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction.” Coron Artery Dis. 15, 1:65-71, 2004. http://www.coronary-artery.com

15. Cui J et al. "Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts." Mol Cell Biochem. 254, 1-2:227-34, 2003. www.wkap.nl

16. Pauley DF and Pepine CJ. “The role of carnitine in myocardial dysfunction.” Am J Kidney Dis. 41, 4 Suppl 4:S35-43, 2003. www.ajkd.org

17. Wilcken DE. "Overview of inherited metabolic disorders causing cardiovascular disease." J Inherit Metab Dis. 26, 2-3:245-57, 2003.

18. Nettleton JA and Katz R. “n-3 long-cahin polyunsaturated fatty acids in type 2 diabetes: a review.” J Amer Diet Assoc. 105, 3:428-40, 2005. www.adajournal.org

19. Mozaffarian D et al. "Fish intake and risk of incident atrial fibrillation." Circulation. 110:368-73, 2004. http://circ.ahajournals.org/

20. Iso H. "Intake of fish and omega-3 fatty acids and risk of stroke in women." JAMA. 285, 3:304-12, 2001. www.jama.com

21. [No authors listed.] "Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell-Infarto miocardio." Lancet. 354, 9177:447-55, 1999. www.thelancet.com

22. Raitt MH et al. “Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.” JAMA. 293, 23:2884-91, 2005. www.jama.com

23. Leaf A et al. “Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.” Circulation. 112, 18:2762-8, 2005. http://circ.ahajournals.org

24. Geelen A et al. “Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans.” Am J Clin Nutr. 81, 2:416-20, 2005. www.ajcn.org

25. Holguin F et al. “Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly.” Chest. 127, 4:1102-7, 2005. www.chestjournal.org

26. Esterhuyse AJ et al. “Dietary red palm oil improves reperfusion cardiac function in the isolated perfused rat heart of animals fed a high cholesterol diet.” Prostaglandins Leukot Essent Fatty Acids. 72, 3:153-61, 2005. http://www.sciencedirect.com/science/journal/09523278

27. Toit ED et al. “Dietary red palm oil supplementation protects against the consequences of global ischemia in the isolated perfused rat heart.” Asia Pac J Clin Nutr. 14, 4:340-7, 2005.

28. Dauchet L et al. “Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies.” Neurology. 65, 8:1193-7, 2005. www.neurology.org

29. Hak AE et al. "Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke." Stroke. 35, 7:1584-8, 2004. http://stroke.ahajournals.org/

30. Chang CY et al. “Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.” Nutrition. 21, 10:987-93, 2005. http://www.sciencedirect.com/science/journal/08999007

31. Kabagambe EK et al. “Some dietary and adipose tissue carotenoids are associated with the risk of nonfatal acute myocardial infarction in Costa Rica.” J Nutr. 135, 7:1763-9, 2005. www.nutrition.org

32. Yamamoto J et al. “Tomatoes have natural anti-thrombotic effects.” Br J Nutr. 90, 6:1031-38, 2003. www.nutritionsociety.org.uk/bjn/

33. Rissanen TH et al. "Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study." Br J Nutr. 85, 6:749-54, 2001. www.cabi-publishing.org/journals/bjn

34. Arab L and Steck S. “Lycopene and cardiovascular desease.” Amer J Clin Nutr. 71, 6:1691S-95S, 2000. www.ajcn.org

35. Hussein G et al. “Antihypertensive and neuroprotective effects of astaxanthin in experimental animals.” Biol Pharm Bull. 28, 1:47-52, 2005. www.jstage.jst.go.jp/browse/bpb

36. Gross GJ, Lockwood SF. "Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax™)." Life Sci. 75:215-24, 2004. www.sciencedirect.com/science/journal/00243205

37. Naito Y et al. “Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice.” Antioxid Redox Signal. 5, 1:139-44, 2003. www.liebertonline.com

38. Lee IM et al. “Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.” JAMA. 294, 1:56-65, 2005. www.jama.com

39. Lonn E et al. “Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.” JAMA. 293, 11:1338-47, 2005. www.jama.com

40. Khanna S et al. “Neuroprotective properties of the natural vitamin E alpha-tocotrienol.” Stroke. 36, 10:2258-64, 2005. http://stroke.ahajournals.org

41. Krantzopoulos P et al. “The possible role of oxidative stress in heart failure and the potential of antioxidant intervention.” Med Sci Monit. 9, 6:RA120-5, 2003. www.medscimonit.com

42. Ullegaddi R et al. “Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke.” Eur J Clin Nutr. 59, 12:1367-73, 2005. www.nature.com/ecjn/

43. Dusinska M et al. “Nutritional supplementation with antioxidants decreases chromosomal damage in humans.” Mutagenesis. 18, 4:371-6, 2003. http://mutage.oupjournals.org

44. Wei WQ et al. "Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke and total death." Am J Clin Nutr. 79, 1:80-5, 2004. www.ajcn.org

45. Gums JG. "Magnesium in cardiovascular and other disorders." Am J Health Syst Pharm. 61, 15:1569-76, 2004.

46. Umesawa M et al. “Dietary intake of calcium in relation to mortality from cardiovascular disease: the JACC Study.” Stroke. 37, 1:20-6, 2006. http://stroke.ahajournals.org/

47. Gualler E et al. “Low toenail chromium concentration and increased risk of nonfatal myocardial infarction.” Am J Epidemiol. 162, 2:157-64., 2005. http://aje.oupjournals.org

48. Li Y et al. “Marginal dietary copper restriction induces cardiomyopathy in rats.” J Nutr. 135, 9:2130-6, 2005. www.nutrition.org

49. Holmquist C et al. “Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women--Stockholm Heart Epidemiology Program (SHEEP).” J Nutr. 133, 8:2650-4, 2003. www.nutrition.org

50. Lee BJ et al. "Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration." Nutrition. 19, 7-8:577-83, 2003. www.elsevier.com/locate/nut

51. Hernandez-Diaz S et al. "Dietary folate and the risk of nonfatal myocardial infarction." Epidemiology. 13, 6:700-6, 2002.

52. Spence JD et al. “Vitamin Intervention For Stroke Prevention trial: an efficacy analysis.” Stroke. 36, 11:2404-9, 2005. http://stroke.ahajournals.org/

53. Ullegaddi R, Powers HJ, Gariballa SE. "B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke." Clin Sci (Lond). 107, 5:477-84, 2004.

54. Schnyder G et al. "Effect of homocysteine-lowering therapy with folic acid, vitamin B12 and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial." JAMA. 288, 8:973-9, 2002. www.jama.com

55. Wang Y et al. “Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage.” Exp Neurol. 193, 1:75-84, 2005. http://www.sciencedirect.com/science/journal/00144886

56. Siddiqui IA et al. "Antioxidants of the beverage tea in promotion of human health." Antioxid Redox Signal. 6, 3:571-82, 2004. www.liebertpub.com/publication.aspx?pub_id=4

57. Arts IC et al. “Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study.” Am J Clin Nutr. 74, 2:227-32, 2001. www.ajcn.org

58. Geleijnse JM et al. “Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study.” Am J Clin Nutr. 75, 5:880-6, 2002. www.ajcn.org

59. Garcia-Estrada J et al. "An alpha-lipoic acid-vitamin E mixture reduces post-embolism lipid peroxidation, cerebral infarction and neurological deficit in rats." Neurosci Res. 47, 2:219-24, 2003.

60. Kwong LK et al. "Effects of coenzyme Q10 administration on its tissue concentrations, mitochondrial oxidant generation and oxidative stress in the rat." Free Rad Biol Med. 33, 5:627-38, 2002. www.elsevier.com/locate/freeradbiomed

61. Tran MT et al. "Role of coenzyme Q10 in chronic heart failure, angina and hypertension." Pharmacotherapy. 21, 7:797-806, 2001. www.iospress.nl/site/html/02770008.html

62. Weant KA and Smith KM. “The role of coenzyme Q10 in heart failure.” Ann Pharmacother. 39, 9:1522-6, 2005. www.theannals.com

63. Salles JE et al. “Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10.” Diabetes Res Clin Pract. Oct 24, 2005 [Epub ahead of print.] www.sciencedirect.com/science/journal/01688227

64. Sarter B. "Coenzyme Q10 and cardiovascular disease: a review." J Cardiovasc Nurs. 16, 4:9-20, 2002.

65. Carter O et al. “D-Ribose supplementation improves peak exercise capacity and ventilatory efficiency in heart failure patients.” J Amer Coll Cardiol. 45, 3SA:185, 2005. www.acc.org

66. Sharma R et al. “D-Ribose improves Doppler TEI myocardial performance index and maximal exercise capacity in stage C heart failure.” JMCC. 38, 5:835, 2005.

67. Perkowski D et al. “Pre-surgical loading of oral D-ribose improves cardiac index in patients undergoing “off” pump coronary artery revascularization.” FASEB j. 19, 4:A695, 2005.

68. Degenring FH et al. "A randomized double blind placebo controlled clinical trial of a standardized extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II." Phytomedicine. 10, 5:363-9, 2003. www.urbanfischer.de/journals/frame_template.htm?/journals/phytomed/phytmed.htm

69. Habs M. "Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442." Forsch Komplementarmed Klass Naturheilkd. 11 Suppl. 1:36-9, 2004.

70. Pittler MH, Schmidt K, Ernst E. "Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials." Am J Med. 114, 8:665-74, 2003.

71. Mahady GB. "Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature." J Cardiovasc Nurs. 16, 4:21-32, 2002.

72. Rioufol G et al. “Ginkgo biloba extract EGb 761 attenuates myocardial stunning in the pig heart.” Basic Res Cardiol. 98, 1:59-68, 2003. http://www.springerlink.com/link.asp?id=401550

73. Sasaki Y et al. “Effects of Ginkgo biloba extract (EGb 761) on cerebral thrombosis and blood pressure in stroke-prone spontaneously hypertensive rats.” Clin Exp Pharmacol Physiol. 29, 11:963-7, 2002. http://www.blackwell-synergy.com/loi/cep

74. Zeng X et al. “Ginkgo biloba for acute ischaemic stroke.” Cochrane Database Syst Rev. 4:CD003691, 2005. http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME

75. Rohdewald P. "A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology." Int J Clin Pharmacol Ther. 40, 4:158-68, 2002.

76. Liu X et al. “Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients.” Life Sci. 74, 7:855-62, 2004. www.sciencedirect.com/science/journal/00243205

77. Belcaro G et al. “Venous ulcers: microcirculatory improvement and faster healing with local use of pycnogenol.” Angiology. 56, 6:699-705, 2005.

78. Fu XC et al. “Vasodilatation produced by orientin and its mechanism study.” Biol Pharm Bull. 28, 1:37-41, 2005. www.jstage.jst.go.jp/browse/bpb

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines